about
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is ...
Read More
3.21
0.26
(8.81%)
1.5M
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for NRX Pharma Inc is on 15 May 2026 for the purpose of NRX Pharmaceuticals Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
NRX Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..